HK1151801A1 - 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid - Google Patents

15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid

Info

Publication number
HK1151801A1
HK1151801A1 HK11105765.9A HK11105765A HK1151801A1 HK 1151801 A1 HK1151801 A1 HK 1151801A1 HK 11105765 A HK11105765 A HK 11105765A HK 1151801 A1 HK1151801 A1 HK 1151801A1
Authority
HK
Hong Kong
Prior art keywords
methylene
hydroxy
carboxylic acid
carboxylic
acid
Prior art date
Application number
HK11105765.9A
Other languages
English (en)
Inventor
Ulrich Klar
Joachim Kuhnke
Rolf Bohlmann
Jan Huebner
Sven Ring
Thomas Frenzel
Frederik Menges
Steffen Borden
Hans Peter Muhn
Katja Prelle
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40627627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1151801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HK1151801A1 publication Critical patent/HK1151801A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
HK11105765.9A 2007-12-29 2011-06-08 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid HK1151801A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007063501A DE102007063501A1 (de) 2007-12-29 2007-12-29 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
PCT/EP2008/011162 WO2009083269A1 (de) 2007-12-29 2008-12-23 15,16-METHYLEN-17-HYDROXY-19-NOR-21-CARBONSÄURE-STEROID γ-LACTON-DERIVAT, DESSEN VERWENDUNG UND DAS DERIVAT ENTHALTENDE ARZNEIMITTEL

Publications (1)

Publication Number Publication Date
HK1151801A1 true HK1151801A1 (en) 2012-02-10

Family

ID=40627627

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11105765.9A HK1151801A1 (en) 2007-12-29 2011-06-08 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid

Country Status (25)

Country Link
US (1) US20110015162A1 (es)
EP (1) EP2238150B1 (es)
JP (1) JP5643107B2 (es)
KR (1) KR20100094999A (es)
CN (1) CN101910191B (es)
AR (1) AR069965A1 (es)
AU (1) AU2008342913A1 (es)
BR (1) BRPI0821432A2 (es)
CA (1) CA2708394C (es)
CL (1) CL2008003920A1 (es)
CO (1) CO6300840A2 (es)
DE (1) DE102007063501A1 (es)
DO (1) DOP2010000200A (es)
EA (1) EA201001006A1 (es)
EC (1) ECSP10010319A (es)
ES (1) ES2397972T3 (es)
HK (1) HK1151801A1 (es)
IL (1) IL205981A0 (es)
NZ (1) NZ586452A (es)
PA (1) PA8809901A1 (es)
PE (1) PE20091186A1 (es)
TW (1) TW200938206A (es)
UY (1) UY31583A1 (es)
WO (1) WO2009083269A1 (es)
ZA (1) ZA201005394B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity
KR200497382Y1 (ko) 2023-05-22 2023-10-25 주식회사밀알 마감판 체결이 용이한 침대 프레임 구조

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918463A (en) 1958-06-12 1959-12-22 Searle & Co 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
CA2708394A1 (en) 2009-07-09
AU2008342913A1 (en) 2009-07-09
JP5643107B2 (ja) 2014-12-17
EP2238150A1 (de) 2010-10-13
TW200938206A (en) 2009-09-16
WO2009083269A1 (de) 2009-07-09
KR20100094999A (ko) 2010-08-27
ECSP10010319A (es) 2010-08-31
DE102007063501A1 (de) 2009-07-02
DOP2010000200A (es) 2010-07-31
CN101910191A (zh) 2010-12-08
US20110015162A1 (en) 2011-01-20
IL205981A0 (en) 2010-11-30
CN101910191B (zh) 2013-07-31
CL2008003920A1 (es) 2010-01-22
EA201001006A1 (ru) 2011-02-28
PA8809901A1 (es) 2009-12-16
JP2011507926A (ja) 2011-03-10
CA2708394C (en) 2015-06-16
AR069965A1 (es) 2010-03-03
EP2238150B1 (de) 2012-10-24
ZA201005394B (en) 2014-01-29
BRPI0821432A2 (pt) 2015-06-16
NZ586452A (en) 2012-04-27
CO6300840A2 (es) 2011-07-21
UY31583A1 (es) 2009-08-03
PE20091186A1 (es) 2009-09-06
ES2397972T3 (es) 2013-03-12

Similar Documents

Publication Publication Date Title
IL206765A0 (en) 4,5-dihydro-oxazol-2-yl-amine derivatives
EP2361902A4 (en) 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
IL201973A0 (en) 3,3-spiroindolinone derivatives
IL213787A0 (en) Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
EP2136810A4 (en) NOVEL 1,8-NAPHTHYRIDINE COMPOUNDS
IL225694A0 (en) Compounds 6,5- dihydro-h1-pyridine-2-one
ZA201001797B (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
SI2356123T1 (sl) Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni
EP2202231A4 (en) 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE
IL201444A0 (en) New 4, 8 - diphenyl - polyazanaphthalene derivatives
HK1162032A1 (en) 1,1,1-trifluoro-2-hydroxypropyl compounds 111--2-
ZA201005346B (en) 3,8-diaminotetrahydroquinoline derivative
HK1151801A1 (en) 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid
HK1161684A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds 56- -1h--2-
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
GB0808811D0 (en) Algabe 2.1
GB0813815D0 (en) Corcost Pre 1001,10
PL384214A1 (pl) Drzwi, zwłaszcza do więzień i aresztów
PL383280A1 (pl) Układ do sterowania urządzeń połączonych w sieć, sposób sterowania poprzez otwartą magistralę typu Feldbus urządzeń połączonych w sieć za pomocą magistrali oraz łącznik sterowany przez układ
GB0703180D0 (en) Just two more 200
GB0702468D0 (en) Just two more 30
GB0702063D0 (en) Just Two More 9
GB0702075D0 (en) Just two more 3
GB0702062D0 (en) Just Two More 7
GB0702061D0 (en) Just Two More 4

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171223